If you still think drops “have to” go first, the LiGHT data is a hard chart to ignore.
Prof. Gus Gazzard shares six-year results showing that first-line SLT kept most eyes at target pressure without long-term drops, reduced trabeculectomy rates and offered better visual field preservation than a drops-first approach. It is a clean example of interventional thinking brought to the very start of the glaucoma journey.
Catch the full perspective and see where SLT fits in your own treatment ladder: https://www.glaucoma-laser-assisted-solutions.com/
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
